baber/WOPTO huggingface dataset:
Patent NZ-619759-A (NZ)
Title: Sonic latch mechanism
Inventor: ABLE ROBERT E
IPC: E21B25/02
Filed: 2012-05-30
Abstract: Disclosed is a drilling head assembly (200) particularly for use in wireline drill assemblies for sonic drilling processes. The assembly (200) has a body (220); a spearhead (240) operatively associated with the body (220) and configured to translate axially relative to the body (220); and at least two latches (260) operatively associated with the spearhead (240) and the body (220). The at least two latches (260) are configured to move between an extended position and a retracted position relative to the body (220) in response to axial translation of the spearhead (240) relative to the body (220). In an extended position, the at least two latches (260) cover more than 25% of the circumference of the body (220) adjacent the latches (260).
Patent NZ-621617-A (NZ)
Title: Manufactured to shape headgear and masks
Inventor: FORMICA JUSTIN JOHN
IPC: A62B18/02
Filed: 2012-08-21
Abstract: A headgear assembly (1100) for use in supporting a respiratory mask in position on a patient’s face for positive pressure treatment of the patient, the headgear comprising a fully-fashioned unitary, seamless structure formed in one piece to shape without being cut from a sheet of material. The fully-fashioned unitary, seamless structure includes at least a first headgear component and is configured to facilitate support of a respiratory mask (1130) in position on a patient’s face. The fully-fashioned unitary, seamless structure comprises yarn.
Patent NZ-623917-A (NZ)
Title: Antigen presenting cancer vaccine
Inventor: CORNFORTH ANDREW
IPC: A61P35/00
Filed: 2012-10-22
Abstract: Disclosed is a melanoma vaccine comprising: at least one dendritic cell from a subject that has melanoma; wherein the at least one dendritic cell had been contacted in vitro with at least one melanoma tumour cell from the same subject, wherein the at least one melanoma tumour cell is non-dividing and not treated in vitro with interferon-gamma (IFN-gamma) or an IFN-gamma mimetic, and at least 60% of the melanoma tumour cells are autophagic, and non-apoptotic. Also disclosed is the use of the above-described melanoma vaccine in the manufacture of a medicament for stimulating an immune response against a melanoma-specific antigen in a subject with melanoma.
Patent NZ-629861-A (NZ)
Title: Method for producing arc-welded structural member
Inventor: HOSOMI KAZUAKI
IPC: C22C38/14
Filed: 2013-05-22
Abstract: A method for arc welding Zn-Al-Mg coated steel plates is described. The method seeks to leave a gap (9) between the weld bead (2) and the alloy layer (5), which increases the brittle failure resistance of the plate (1). The bead (2) is created using a welding torch and a shielding gas to shield the melting process from the surrounding atmosphere. Reducing the carbon dioxide (CO2) in the shielding gas creates an oxidising coating. This stops the molten coating region (10) from spreading into contact with the bead (see lower figure). Contact of the molten region (10) with the bead (2) can produce a tensile stress, which can make the plate more susceptible to cracking.
Patent NZ-630388-A (NZ)
Title: High efficiency methods of sex sorting sperm
Inventor: GILLIGAN THOMAS BOYD
IPC: C12N5/076
Filed: 2013-03-04
Abstract: A method of efficiently sorting a sperm sample in a particle sorting instrument comprises a) establishing a sheath fluid stream in the particle sorting instrument; b) flowing a sperm sample into the sheath fluid stream; c) identifying viable X-chromosome bearing sperm and/or viable Y-chromosome bearing sperm in the sperm sample; d) separating the viable X-chromosome bearing sperm and/or the viable Y-chromosome bearing sperm from the remainder of the sperm sample; e) collecting the viable X-chromosome bearing sperm and/or the viable Y-chromosome bearing sperm; f) determining one or more measured sorting parameters in the particle sorting instrument; g) establishing a minimum productivity threshold; h) establishing a minimum purity threshold; i) determining a sorting efficiency based on the measured sorting parameters determined while sorting; and j ) adjusting one or more instrument parameters to increase the sorting efficiency while maintaining the productivity above the minimum productivity threshold and purity above the minimum purity threshold.
Patent NZ-702297-A (NZ)
Title: A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
Inventor: WAETZIG GEORG
IPC: A61P37/00
Filed: 2013-06-14
Abstract: The present invention relates to a use of an active substance selected from nicotinic acid; nicotinamide; tryptophan; nicotinic acid esters; nicotinamide adenine dinucleotide (NAD); nicotinamide adenine dinucleotide phosphate (NADP); an intermediate in the biosynthesis of NAD or NADP selected from the group consisting of N-formylkynurenine, L-kynurenine, 3-hydroxy-L-kynurenine, 3-hydroxyanthranilate, 2-amino-3-carboxymuconate semialdehyde, quinolinate, and beta-nicotinate D-ribonucleotide; a tryptophan dipeptide; or a combination thereof for the manufacture of a pharmaceutical composition for positively influencing the intestinal microbiota, wherein the pharmaceutical composition is adapted or formulated for release of the active substance for topical efficacy in the terminal ileum, the colon or both.
Patent NZ-709825-A (NZ)
Title: Polymeric forms of h-nox proteins
Inventor: KAPP GREGORY
IPC: C07K19/00
Filed: 2013-01-07
Abstract: The invention provides polymeric H-NOX proteins for the delivery of oxygen with longer circulation half-lives compared to monomeric H-NOX proteins. Polymeric H-NOX proteins extravasate into and preferentially accumulate in tumor tissue for sustained delivery of oxygen. The invention also provides the use of H- NOX proteins as radiosensitizers for the treatment of brain cancers.
Patent NZ-710439-A (NZ)
Title: Methods of treating and preventing staphylococcus aureus infections and associated conditions
Inventor: TORRES VICTOR J
IPC: A61K39/00
Filed: 2012-06-19
Abstract: Discloses a composition comprising: one or more Staphylococcus aureus-specific Leukocidin E (LukE) antibodies or fragments thereof, wherein said LukE antibodies and fragment thereof bind to an epitope of LukE, wherein said epitope is selected from the group consisting of amino acid residues 3-13 of SEQ ID NO:11, amino acid residues 32-47 of SEQ ID NO:11, amino acid residues 57-75 of SEQ ID NO:11, amino acid residues 126-139 of SEQ ID NO:11, amino acid residues 151-156 of SEQ ID NO:11, amino acid residues 162-198 of SEQ ID NO:11, amino acid residues 230-273 of SEQ ID NO:11, and amino acid residues 272-283 of SEQ ID NO:11, and a pharmaceutically acceptable carrier, wherein the sequences are as defined in the compete specification. Further discloses treatment of Staphylococcus aureus related conditions.
Patent NZ-713868-A (NZ)
Title: Treatment of cancer using coenzyme q10 combination therapies
Inventor: NARAIN NIVEN
IPC: A61P35/02
Filed: 2014-04-08
Abstract: Use of coenzyme Q10 (CoQ10) in the manufacture of a medicament for treating pancreatic cancer in a subject, wherein the medicament is to be co-administered with and prior to at least one chemotherapeutic agent comprising gemcitabine, the medicament is to be administered by continuous intravenous infusion for at least 24 hours, and administration of the medicament is discontinued or continued after administration of the at least one chemotherapeutic agent.
Patent NZ-713981-A (NZ)
Title: Cenicriviroc compositions and methods of making and using the same
Inventor: MENNING MARK MICHAEL
IPC: A61K31/194
Filed: 2014-05-15
Abstract: The present disclosure relates to pharmaceutical compositions containing cenicriviroc or a salt thereof and fumaric acid, methods for the preparation thereof, and their use in the treatment of diseases or conditions, particularly viruses such as Human Immunodeficiency Virus (HIV).
Patent NZ-728949-A (NZ)
Title: Anti-inflammatory agent comprising a milk-derived disrupted exosome
Inventor: IZUMI HIROHISA
IPC: A61P29/00
Filed: 2015-09-09
Abstract: In one aspect, the invention provides an anti-inflammatory agent, which comprises a milk-derived disrupted exosome of which the form of membrane vesicle is partially or completely disrupted as an active ingredient. In another aspect, the invention provides a method for producing an anti-inflammatory agent, which comprises: the step of removing lipid fraction, cell fraction and casein fraction from milk to prepare a whey fraction, the step of collecting an exosome fraction from the whey fraction, the step of disrupting partially or completely the form of membrane vesicle of the exosome contained in the exosome fraction to prepare a disrupted exosome, and the step of making the disrupted exosome as an active ingredient into a preparation.
Patent NZ-744038-A (NZ)
Title: Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
Inventor: HANSON GUNNAR
IPC: C07H21/00
Filed: 2011-05-27
Abstract: Disclosed are synthetic PMO oligomers of general formula (XVII), or salts thereof which include a 3’-tail moiety, wherein W is O or S; X is hydroxy, optionally substituted alkoxy or optionally substituted amino (which also includes optionally substituted heterocylic rings moieties etc.); Y is O or optionally substituted amino; B is base-pairing moiety; L1 is an optional linker moiety; R19 is hydrogen, a cell-penetrating peptide, a natural or non-natural amino acid, or suitably optionally substituted group (such as protecting group, or residue derived from a cleavable linker); R17 is, at each occurrence, independently absent, hydrogen or an optionally substituted hydrocarbon chain radical; and R18 is a 3’-tail group (such as can be provided following standard deprotection of trityl groups and purification), and where R18 is selected specifically from any of the alternative end groups selected from: trimethoxybenzoyl, 9-fluorene-carboxyl, 4-carbazolylbenzoyl, 4-indazolylonebenzoyl, farnesyl, geranyl, prenyl, diphenylacetyl, chlorodiphenylacetyl, hydroxydiphenylacetyl, triphenylpropionyl, triphenylpropyl, triphenylacetyl, methylsuccinimidyl-cyclohexoyl, thioacetyl, COCH2CH2SSPy, trimethylglycine, lauroyl, triethyleneglycoloyl, succinicacetyl, diphenylphosphoryl, piperidin-4-yl, tritylpiperidin-4-yl, Boc-piperidin-4-yl, hexyn-6-yl, 5-carboxyfluorescein, benzhydryl, p-chlorobenzhydryl, piperazinyl, triphenylphos, acetamide, or methylurea.
Patent NZ-752976-A (NZ)
Title: Terminal apparatus, mobility management entity (mme), control plane function (cpf), and communication control method
Inventor: KAWASAKI Yudai
IPC: H04W60/06
Filed: 2017-08-14
Abstract: The invention relates generally to user equipment, a control device in a core network and communication control methods. The invention seeks to resolve issues relating to lack of means for establishing a session for a terminal or network device supporting various access networks and means for realising communication means for various user data and the like observed in prior art systems. The present invention provides User Equipment (UE) comprising: a transmission and reception unit configured to: send, to a control device performing a session management function in a core network, a first Protocol Data Unit (PDU) session establishment request message with a first Session and Service Continuity (SSC) mode; and send, to the control device, a second PDU session establishment request message with a second SSC mode if the UE receives, from the control device, a PDU session establishment reject message including a cause value indicating that the first SSC mode is not supported, wherein the first SSC mode and the second SSC mode are different.
Patent NZ-756332-A (NZ)
Title: Surgical tool for tissue sizing and transection
Inventor: DRACH GREGORY
IPC: G01B5/08
Filed: 2017-02-07
Abstract: Nerves can be transected for a variety of reasons. Whether the nerve is transected deliberately or by accident, repair of the nerve can be facilitated if a nerve end is cut and free of frayed or damaged areas. Clean nerve ends can be easier to coapt to other nerve ends or grafts and can promote alignment of the axons from each terminal nerve end. In order to obtain a clean cut nerve end, it may be necessary to resection the nerve tissue some distance away from the terminal end, to remove damaged or non-viable tissue at the terminal nerve end. Resection of nerve tissue can be difficult. If done incorrectly it can result in a new terminal nerve end that is crushed, frayed, or that has multiple transection lines caused by the cutting implement making multiple passes or sawing across the tissue. Properly bracing the circumference of the nerve in the area of transection can minimize such damage to the one or more new terminal nerve ends. There are devices that can be used to support a nerve, while a cutting implement is used to transect the nerve. Often these devices do not entirely brace the full circumference and secure the position of the nerve, thus, allowing the nerve to roll or turn during the cutting process. If the resected nerve end is to be coapted to, or inserted into, a graft or implant, the nerve must be measured in vivo, so that an appropriately-sized graft can be selected. It has been demonstrated that when obtaining sizes of nerves during surgical procedures, the measurements are usually inaccurate. In accordance with the current application, sizing forceps are provided for fixing a nerve in place, measuring the diameter of the nerve, and providing an efficient way to resect the nerve. A sizing forceps can have an upper and lower jaw with two or more aligned notches that form apertures for holding a nerve. The apertures can have predetermined sizes that can be used to measure the diameter of a nerve. A slicing slot in the upper and lower jaw allows a nerve within an aperture to be severed to obtain a non-frayed end.
Patent NZ-773822-A (NZ)
Title: Methods and systems for diagnosing and treating health ailments
Inventor: SAMEC NICOLE
IPC: A61B3/135
Filed: 2016-03-16
Abstract: In order to diagnose, monitor, and treat health conditions and ailments, including ophthalmic as well as other conditions and ailments, a wearable augmented reality device is proposed and includes: an augmented reality head-mounted ophthalmic system comprising an augmented reality display platform configured to pass light from the world into an eye of a wearer wearing the head-mounted ophthalmic system; a light source configured to provide augmented reality content on a plurality of depth planes and to project an illumination beam of light into the eye of the wearer to illuminate an anterior or posterior portion of the eye, a cross-sectional beam shape of the illumination beam configured such that a dimension of the cross-sectional beam shape along a superior-inferior direction of the eye is greater than a dimension of the cross-sectional beam shape along a nasal-temporal direction of the eye; and an imaging system configured to track a gaze of the wearer’s eye and to capture an image of the illuminated portion of the wearer’s eye to perform a slit lamp examination to determine health of the eye.
Patent PT-101354-A (PT)
IPC: H01L25/18
Filed: 1993-09-02
Abstract: A method for producing integrated circuit devices including the steps of producing a plurality of integrated circuits on a wafer, each of the integrated circuits including a multiplicity of pads and thereafter slicing the wafer, thereby to define a plurality of integrated circuit elements, and wherein the step of slicing exposes sectional surfaces of the multiplicity of pads. Apparatus for carrying out the method and integrated circuit devices are also described and claimed.
Patent PT-103153-A (PT)
Title: Modular multi-point locking system for door, has central lock provided with main drive mechanism and arranged with auxiliary closure latch, and vertical sliding transmission medium arranged with door
Inventor: ARAMBURU LUIS ANGEL RUANO
IPC: E05B63/14
Filed: 2004-06-22
Abstract: The system has a central lock (1) provided with a main drive mechanism and arranged with an auxiliary closure latch (2). The central lock is arranged in a front part of a door (6). The auxiliary closure latch is arranged at an upper edge of the door. A vertical sliding transmission medium (5) i.e. single tubular bar (8), is arranged with the door and mechanically connected with the central lock. An upper tubular bar (9) and a lower tubular rod (10) are mechanically connected with the central lock.
Patent RU-94026098-A (RU)
Inventor: GLENN KH SHMIDT
IPC: A63B53/02
Filed: 1994-07-13
Abstract: FIELD: sports equipment. SUBSTANCE: golf club has head, handle and shaft. Head has hook base, foot, top and bottom parts. Head has flare portion connected with head. Flare portion has inner wall extending to shaft and round wall portions positioned at an angle to shaft. At least one wall portion has local eccentric surface. Handle has lower end part, which is urged into flare portion. End part is partially flattened in the direction of shaft, when lower end part of handle together with eccentric surface is urged into flare portion. Wall profile defines together with lower end part of handle a gap with axial offset from eccentric surface for receiving adhesive substance, which is applied to lower end part of handle and hardened with following glueing of lower part of handle with wall profile. EFFECT: increased efficiency, simplified construction and enhanced reliability.
Patent RU-94028107-A (RU)
Inventor: DZHON I MEHKOR
IPC: A61K31/42
Filed: 1992-10-06
Abstract: FIELD: organic chemistry. SUBSTANCE: product: derivatives of the formulawhere Z -or; R-,,or; X - O, NH or S; A, B, C, D, E and F every independently is C, N, O or S; R, R, R, Rand Revery independently is hydrogen, (C-C)-alkyl, aryl,-alkylaryl, halogen, cyano, nitro, -NRR,, -(CH)OR, -SR, -SOR, -SONRR, -NRSOR, -NRCOR, -NRCOR, -CONRRor -COR; Rand R, Rand R, Rand Ror Rand Rforming one of pairs can be taken together with formation of 5-7-membered alkyl ring, 6-membered aryl ring, 5-7-membered heteroalkyl ring containing 1 heteroatom N, O or S, or 5-6-membered heteroaryl ring containing 1 or 2 heteroatoms of N, O or S; Rand Revery independently is hydrogen, (C-C)-alkyl, -(CH)R, (C-C)-alkylaryl or can be taken together forming 4-6-membered ring; R- hydrogen, (C-C)-alkyl, (C-C)-alkylaryl, aryl or -(CH)R; Rand Revery independently is -OH, -OR, -OCOR, -CONHRor cyano-group; R- hydrogen, (C-C)-alkyl, aryl or (C-C)-alkylaryl; R- hydrogen, -ORor -NHCOR; R- (C-C)-alkyl or (C-C)-alkylaryl; n = 0, 1 or 2; m = 1, 2 or 3; q = 2, 3 or 4; w = 2, 3 or 4. Above-mentioned aryl groups and aryl moieties of above-mentioned alkylaryl groups are independently phenyl or substituted phenyl, being substituted phenyl can be substituted with one-three (C-C)-alkyls, halogens, hydroxy-groups, cyano-groups, carboxamido-groups, nitro-groups and (C-C)-alkoxy-groups; broken line - nonobligatory double bond, and their pharmaceutically acceptable salts. Synthesized compounds show strong psychotherapeutic effect, they are agonists of serotonine (5_ HT) and can be used for treatment patients with different pathology: depression, fear, different pains, vascular disorders, etc. as a result of serotoninergic neurotransmission damage. They can be used also as hypotensive and vasodilator agents. EFFECT: improved method of synthesis, high effectiveness of synthesized compounds.
Patent RU-94030305-A (RU)
Inventor: LAPSHIN P S
IPC: E21B43/25
Filed: 1994-08-06
Abstract: FIELD: mining industry. SUBSTANCE: method relates to testing of holes drilled for oil and gas and allows for better clearing of down-hole zone of reservoir, for increasing its permeability and hydraulic conductivity by way of high depressions in pumping out reservoir fluids and acid treatment which are performed in several cycles. According to data resulted from two running-downs of bed testers with similar periods of inflow T, determined are hydraulic conductivity of reservoir down-hole zone after action of depressions and acid treatment according to following formula:, by means of iterating calculations at similar values of first underlogarithmic expression. Then evaluated is efficiency of clearing down-hole zone of reservoir according to changing its hydraulic conductivity, and conclusions are made about further plan of intensifying inflow, where: B - volumetric coefficient of reservoir fluid, r•hK(β+β) - depression of reservoir pressure, T - inflow time, ΔP - product of effective thickness by effective porosity of reservoir, r - radius of bore-hole, βи β- compressibility of reservoir liquid and reservoir pores. EFFECT: high efficiency.
Patent RU-94036065-A (RU)
Inventor: AVVAKUMOV A S
IPC: B61H13/20
Filed: 1994-09-26
Abstract: FIELD: railway transport; freight car brake systems. SUBSTANCE: mechanical part of freight car brake has brake cylinders rigidly coupled with freight car structure. Novelty in design of mechanical part is that middle portion of head bell crank is hinge-coupled with rod whose opposite end is hinge-connected with bracket rigidly coupled with car structure, and driven arm of head bell crank is either directly connected with middle portion of bell crank connected through brake rigging regulator and rod connected with regulator; one end of bell crank is hinge-coupled with bracket rigidly secured on frame or car body. Opposite end of rear bell crank is connected by rod with bell crank of bogie brake rigging. Automatic brake rigging regulator can be loaded either in brake cylinder, or in one of rods coupling the bell cranks. Middle portion of head bell crank has joint connected with bracket hinge-coupled with car structure. EFFECT: enhanced reliability of brake system in service.
Patent RU-94037968-A (RU)
Inventor: MIKHAEHL B
IPC: C07D209/56
Filed: 1994-10-20
Abstract: FIELD: organic chemistry. SUBSTANCE: tricyclic derivatives of pyrrole of the formula (I)where R-Rmean hydrogen, halogen, lower alkyl, phenyl, cycloalkyl or lower alkoxy, respectively, and Rmeans additionally lower alkoxycarbonyl, acylhydroxy or mesylhydroxy; R-Rmean hydrogen or lower alkyl, respectively; X means -CHCH    -, -CH=C    -, -YCH-, -CH= CH- or -(CRR);; Rand Rmean hydrogen, phenyl, lower alkyl or halogen, respectively; n = 1-3 and Y means O or S, and pharmaceutically acceptable salts of the basic compounds of the formula (I)with acids. Synthesized compounds were used in neurology, cardiology and gastroenterology for prevention and treatment of diseases. EFFECT: improved method of synthesis, high effectiveness.
Patent RU-95102528-A (RU)
Inventor: D JACHENKO V S
IPC: B64C27/00
Filed: 1995-02-21
Abstract: FIELD: aeronautical engineering. SUBSTANCE: rotor has many blades at angle of attack always lesser than 45 deg; blades are enclosed in circular envelope-tunnel. Total area of projection of all blades of rotor on plane perpendicular to axis of rotation always exceeds three quarters of area of circle or ring described by them, thus actually converting the rotor into annular slotted (lattice) wing whose theory is put forward by S.A.Tchaplygin. The most effective field of application is for vertical take-off and landing aircraft beginning with those driven by man power having cargo capacity of 100 to 150 kg and up to multi-engined flying supercranes of cargo hoisting capacity of 100 to 300 tons and even more. Rotor may be made of concentric sections inserted one in other and its diameter may exceed 100 m. Rotor may be used as tractor propellers of piston-engined aeroplanes, aerosleigh, planing boats, propellers of displacement-type ships, impellers of axial-flow fans, wind-power units, air supercharger in Hovercraft and other transport facilities. EFFECT: enhanced reliability. 5 cl, 3 dwg